Long-Term Analysis of All 695 Patients Enrolled in Novocure’s Phase 3 Pivotal Trial in Newly Diagnosed Glioblastoma Confirms Successful Interim Analysis Results and Demonstrates Superior Two- and Four-Year Survival Rates This is what we have been waiting for. The final results of the Optune trial for newly diagnosed GBM. There was some resistance to accepting Optune as the standard of care because the results presented 2 years ago were "just preliminary". The final results are actually better than the preliminary results!
Now the next step is getting insurance to pay for it. Already most non-Medicare plans do pay for it, but Medicare has been hesitating. We had a petition a while ago to help nudge Medicare toward paying for it. I presented it to them and we did come close and I think it did help - but we had that problem of results being preliminary. We are going to try again. I resurrected the survey - and updated it to show current results. Please sign it and have your friends and family members sign it. IF you already signed it last time - you do not need to sign it again - it is still valid. If you aren't sure, email me your name and address and I will check it for you. Go to https://virtualtrials.com/activism.cfm for details and to sign!
